◀ Back to TP53
S100A6 — TP53
Pathways - manually collected, often from reviews:
Protein-Protein interactions - manually collected from original source literature:
Studies that report less than 10 interactions are marked with *
Text-mined interactions from Literome
Króliczak et al., Acta biochimica Polonica 2008
(Neoplasms) :
Separate overexpression of either Sp1 or of NFkappaB only partially counteracted the
p53 inhibitory
effect on the
S100A6 promoter, while simultaneous overexpression of both these transactivators resulted in a complete abolishment of the p53 inhibitory effect on this promoter
Tsoporis et al., J Biol Chem 2008
(Inflammation) :
These results demonstrate that
S100A6 is
induced by tumor necrosis factor-alpha via an NF-kappaB dependent mechanism, serving a role in homeostasis to limit tumor necrosis factor-alpha induced apoptosis by regulating
p53 phosphorylation
Słomnicki et al., Int J Biochem Cell Biol 2009
:
As revealed by electrophoretic mobility shift assay ( EMSA )
S100A6 does not
affect p53 binding to DNA
Zimmermann et al., Proteomics 2009
:
Proteomic profiling in distinct cellular compartments of tumor cells reveals
p53 dependent upregulation of
S100A6 upon induction of telomere dysfunction